USTEKID Trial
Trial of a new medication in people with Type 1 diabetes aged 12-18 and within 100 days of diagnosis.
Immunotherapy Treatment for Type 1 Diabetes
Colin Dayan explains immunotherapy for T1D – here interviewed by Vivienne Parry OBE prior to a plenary lecture at the EASD in Berlin Sept 2018.
News
Our Partners
The consortium is funded by DUK and JDRF with a network of partners.
Join our research and help change the future of Type 1 Diabetes
Twitter Feeds
.@T1D_UK is looking for people with #type1 #diabetes to take part in a survey on research. Children & adults with #type1 & also parents/ family - get involved in helping to shape #type1 clinical trials so more people with #T1D take part! Learn more: https://jdrf.org.uk/our-research/how-you-can-get-involved/projects-you-can-join/ #GBDoc https://twitter.com/DUK_research/status/1221882092214030336